Golden age of immunoengineering

Immunol Rev. 2023 Nov;320(1):4-9. doi: 10.1111/imr.13283. Epub 2023 Oct 23.

Authors

Wilson W Wong¹, Wendell A Lim²

Affiliations

¹ Biomedical Engineering and Biological Design Center, Boston University, Boston, Massachusetts, USA.
² Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California, USA.

PMID: 37872646
PMCID: PMC10841587 (available on 2024-11-01)
DOI: 10.1111/imr.13283

No abstract available

Keywords: CAR; CRISPR; Immunoengineering; antibodies; autoimmunity; cancer; immunotherapy; receptors.

MeSH terms

Humans
Immunotherapy*
Immunotherapy, Adoptive
Neoplasms*

Grants and funding